Healthcare | May 08, 2026
Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
The company previously completed a $150 million venture investment, acquisition, and recapitalization
Renalyx will continue operating as an independent unit within the group
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
The Dengue IgG/IgM Rapid Test is a diagnostic tool used to detect antibodies against the dengue virus in blood samples
Achira is engaged in development and commercialization of PoC medical test kits in India
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
The news report stating Krsnaa Diagnostics has accepted Rs 100 crores of undisclosed income is incorrect and baseless.
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
Subscribe To Our Newsletter & Stay Updated
